Milestone Pharmaceuticals Inc. (MIST)
NASDAQ: MIST · IEX Real-Time Price · USD
3.94
-0.13 (-3.19%)
At close:
May 31, 2023, 4:00 PM
4.05
+0.11 (2.79%)
After-hours:
May 31, 2023, 4:40 PM EDT
Milestone Pharmaceuticals Market Cap
Milestone Pharmaceuticals has a market cap or net worth of $131.43 million as of June 1, 2023. Its market cap has decreased by -21.16% in one year.
Market Cap
131.43M
Enterprise Value
80.17M
1-Year Change
-21.16%
Ranking
Category
Stock Price
$3.94
Market Cap Chart
Since May 9, 2019, Milestone Pharmaceuticals's market cap has decreased from $355.80M to $131.43M, a decrease of -63.06%. That is a compound annual growth rate of -21.75%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 30, 2023 | 135.80M | 2.26% |
| May 26, 2023 | 132.80M | -2.92% |
| May 25, 2023 | 136.80M | -4.60% |
| May 24, 2023 | 143.40M | - |
| May 23, 2023 | 143.40M | 4.82% |
| May 22, 2023 | 136.80M | -4.60% |
| May 19, 2023 | 143.40M | 4.60% |
| May 18, 2023 | 137.10M | 2.47% |
| May 17, 2023 | 133.80M | 2.29% |
| May 16, 2023 | 130.80M | -6.84% |
| May 15, 2023 | 140.40M | -4.36% |
| May 12, 2023 | 146.80M | 3.53% |
| May 11, 2023 | 141.80M | 9.24% |
| May 10, 2023 | 129.80M | -0.54% |
| May 9, 2023 | 130.50M | - |
| May 8, 2023 | 130.50M | 9.21% |
| May 5, 2023 | 119.50M | -0.25% |
| May 4, 2023 | 119.80M | - |
| May 3, 2023 | 119.80M | 2.57% |
| May 2, 2023 | 116.80M | -3.07% |
| May 1, 2023 | 120.50M | -0.25% |
| Apr 28, 2023 | 120.80M | -0.58% |
| Apr 27, 2023 | 121.50M | -1.62% |
| Apr 26, 2023 | 123.50M | -2.60% |
| Apr 25, 2023 | 126.80M | -3.35% |
View and export this data all the way back to 2019.
Start Free Trial.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Rhythm Pharmaceuticals, Inc. | 927.87M |
| CymaBay Therapeutics, Inc. | 853.24M |
| Aldeyra Therapeutics, Inc. | 548.86M |
| Omeros Corporation | 363.15M |
| Fusion Pharmaceuticals Inc. | 270.07M |
| Beyond Air, Inc. | 154.67M |
| Vaccitech plc | 94.01M |
| Mainz Biomed B.V. | 77.54M |
| Co-Diagnostics, Inc. | 32.68M |